69 related articles for article (PubMed ID: 12376811)
1. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
2. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure.
Buchen S; Ngampolo D; Melton RG; Hasan C; Zoubek A; Henze G; Bode U; Fleischhack G
Br J Cancer; 2005 Feb; 92(3):480-7. PubMed ID: 15668713
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate level discrepancy post-glucarpidase: A pediatric case series and review of literature.
Kibby D; Trinkman H
Pediatr Blood Cancer; 2024 Mar; 71(3):e30831. PubMed ID: 38149827
[TBL] [Abstract][Full Text] [Related]
4. Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.
Smith SW; Nelson LS
J Med Toxicol; 2008 Jun; 4(2):132-40. PubMed ID: 18570175
[No Abstract] [Full Text] [Related]
5. Neurocognitive outcomes of children with osteosarcoma treated with methotrexate.
Shima H; Sato S; Takimoto T; Sakai M; Hashida N; Isshiki K; Shimada H
Pediatr Int; 2023 Jan; 65(1):e15487. PubMed ID: 36799122
[No Abstract] [Full Text] [Related]
6. Understanding and managing methotrexate nephrotoxicity.
Widemann BC; Adamson PC
Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate overdose in clinical practice.
Pannu AK
Curr Drug Metab; 2019; 20(9):714-719. PubMed ID: 31385765
[TBL] [Abstract][Full Text] [Related]
8. Drug induced nephrotoxicity- A mechanistic approach.
Sharma V; Singh TG
Mol Biol Rep; 2023 Aug; 50(8):6975-6986. PubMed ID: 37378746
[TBL] [Abstract][Full Text] [Related]
9. Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available.
Rosales A; Madrid A; Muñoz M; Dapena JL; Ariceta G
Front Pediatr; 2021; 9():635152. PubMed ID: 34490152
[No Abstract] [Full Text] [Related]
10. Dosing Recommendations for Pediatric Patients With Renal Impairment.
Al-Khouja A; Park K; Anderson DJC; Young C; Wang J; Huang SM; Khurana M; Burckart GJ
J Clin Pharmacol; 2020 Dec; 60(12):1551-1560. PubMed ID: 32542790
[TBL] [Abstract][Full Text] [Related]
11. DAMPAned Methotrexate: A Case Report and Review of the Management of Acute Methotrexate Toxicity.
Young A; Beriault D; Jung B; Nikonova A; Abosh D; Lee S; Zaltzman J; Perl J
Can J Kidney Health Dis; 2019; 6():2054358119895078. PubMed ID: 31903191
[TBL] [Abstract][Full Text] [Related]
12. Renal replacement therapy in the management of intoxications in children: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) workgroup.
Raina R; Grewal MK; Blackford M; Symons JM; Somers MJG; Licht C; Basu RK; Sethi SK; Chand D; Kapur G; McCulloch M; Bagga A; Krishnappa V; Yap HK; de Sousa Tavares M; Bunchman TE; Bestic M; Warady BA; de Ferris MD
Pediatr Nephrol; 2019 Nov; 34(11):2427-2448. PubMed ID: 31446483
[TBL] [Abstract][Full Text] [Related]
13. Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study.
Demiralp B; Koenig L; Kala J; Feng C; Hamlett EG; Steele-Adjognon M; Ward S
Clinicoecon Outcomes Res; 2019; 11():129-144. PubMed ID: 30799942
[TBL] [Abstract][Full Text] [Related]
14. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Ramsey LB; Balis FM; O'Brien MM; Schmiegelow K; Pauley JL; Bleyer A; Widemann BC; Askenazi D; Bergeron S; Shirali A; Schwartz S; Vinks AA; Heldrup J
Oncologist; 2018 Jan; 23(1):52-61. PubMed ID: 29079637
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for treatment of renal injury during cancer chemotherapy 2016.
Horie S; Oya M; Nangaku M; Yasuda Y; Komatsu Y; Yanagita M; Kitagawa Y; Kuwano H; Nishiyama H; Ishioka C; Takaishi H; Shimodaira H; Mogi A; Ando Y; Matsumoto K; Kadowaki D; Muto S
Clin Exp Nephrol; 2018 Feb; 22(1):210-244. PubMed ID: 28856465
[No Abstract] [Full Text] [Related]
16. Recovery of methotrexate-induced anuric acute kidney injury after glucarpidase therapy.
Harms J; Khawaja A; Taylor M; Han X; Mrug M
SAGE Open Med Case Rep; 2017; 5():2050313X17705050. PubMed ID: 28491318
[TBL] [Abstract][Full Text] [Related]
17. Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
[TBL] [Abstract][Full Text] [Related]
18. Sequential use of hemoperfusion and single-pass albumin dialysis can safely reverse methotrexate nephrotoxicity.
Chan WK; Hui WF
Pediatr Nephrol; 2016 Oct; 31(10):1699-703. PubMed ID: 27335061
[TBL] [Abstract][Full Text] [Related]
19. High-flux hemodialysis after administering high-dose methotrexate in a patient with posttransplant lymphoproliferative disease and impaired renal function.
Reshetnik A; Scheurig-Muenkler C; van der Giet M; Tölle M
Clin Case Rep; 2015 Nov; 3(11):932-6. PubMed ID: 26576275
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
